Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis.
Bruce E StroberLaura C CoatesMark G LebwohlAtul DeodharEvan LeibowitzKatelyn RowlandAlexa P KollmeierMegan MillerYanli WangShu LiSoumya D ChakravartyDaphne ChanMay ShawiYa-Wen YangDiamant ThaҫiProton RahmanPublished in: Drug safety (2023)
Clinicaltrials.gov identifiers: NCT01483599, NCT02207231, NCT02207244, NCT02203032, NCT02905331, NCT03090100, NCT02325219, NCT02319759, NCT03162796, NCT03158285, and NCT03796858.